Association of modified textbook outcome and overall survival after surgery for colorectal liver metastases: A nationwide analysis
Kelly R. Voigt(Erasmus MC Cancer Institute), Steven J. Oosterling(Spaarne Ziekenhuis), Koop Bosscha(Jeroen Bosch Ziekenhuis), Mike S.L. Liem(Medisch Spectrum Twente), J. Sven D. Mieog(Leiden University Medical Center), Ronald M. van Dam(Maastricht University Medical Centre), Gijs A. Patijn(Isala), Eric J.T. Belt(Albert Schweitzer Ziekenhuis), Wouter K. G. Leclercq(Radboud University Nijmegen), Wouter J.M. Derksen(University Medical Center Utrecht), Carlijn I. Buis, Michelle R. de Graaff(Dutch Institute for Clinical Auditing), Geert Kazemier(European Organisation for Research and Treatment of Cancer), Marcel den Dulk(Leiden University Medical Center), Joost M. Klaase(University Medical Center Groningen), Paul D. Gobardhan(Amphia Ziekenhuis), Peter B. van den Boezem(Radboud University Nijmegen), Dirk J. Grünhagen(Erasmus MC), Hans Torrenga E. Manusama, Rutger J. Swijneburg(Amsterdam University Medical Centers), Hendrik Marsman(OLVG), Niels F.M. Kok(The Netherlands Cancer Institute), Maarten Vermaas(Association of British Orchestras), Tjarda N. van Heek, Cornelis Verhoef(Erasmus MC Cancer Institute)
Cited by 5
Related Papers
Definition and grading of anastomotic leakage following anterior resection of the rectum: A proposal by the International Study Group of Rectal Cancer
|Surgery|2009|1.5k
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
|Journal of Clinical Oncology|2020|1.1k
Endoscopic or surgical step-up approach for infected necrotising pancreatitis: a multicentre randomised trial
|The Lancet|2017|732
The PD-1/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph Nodes
|Cancer Cell|2020|683
Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial
|The Lancet. Gastroenterology & hepatology|2019|597